Cancer Research

Cancer Research at Creighton University

Cancer research at Creighton University focuses on saving lives by finding new ways to treat, prevent and detect cancer. Scholars from disciplines ranging from biomedical sciences to physics conduct research on many different types of cancer, including breast cancer, head and neck cancer, leukemia, lymphoma, prostate cancer, and skin cancer, among others. Often working collaboratively and attacking a problem from multiple angles, their work offers hope for a future where more cancers are treatable and treatment options are better.

    In biomedical sciences, Sándor Lovas, PhD, works to identify peptides to target molecules that may contribute to causes of smoking-related diseases. Lovas relies on computational chemistry to process his data, and recently received a National Science Foundation (NSF) Experimental Program to Stimulate Competitive Research (EPSCoR) award to boost the computational power available to researchers across the university. In the lab of Laura Hansen, PhD, she and her team examine skin cancer at the molecular level. Hansen and Lovas are part of an interdisciplinary research team who have steadily been working on research related to LB595, a program funded by the state to examine cancer and smoking related diseases. Hansen has identified novel signifying molecules that might serve as targets for treating cancer.

    In biomedical sciences, Sándor Lovas, PhD, works to identify peptides to target molecules that may contribute to causes of smoking-related diseases. Lovas relies on computational chemistry to process his data, and recently received a National Science Foundation (NSF) Experimental Program to Stimulate Competitive Research (EPSCoR) award to boost the computational power available to researchers across the university. In the lab of Laura Hansen, PhD, she and her team examine skin cancer at the molecular level. Hansen and Lovas are part of an interdisciplinary team who have steadily been working on research related to LB595, a program funded by the state to examine cancer and smoking related diseases. Hansen has identified novel signifying molecules that might serve as targets for treating cancer.

    In addition to working with Hansen, Lovas, and the rest of the LB595 group, Xian-Ming Chen, MD, in medical microbiology and immunology, focuses on breast and prostate cancer. His current work examines how to prevent infection in the compromised immune system of cancer patients. Also in medical microbiology and immunology, Patrick Swanson, PhD, studies leukemia and lymphoma at the DNA level.

    Another member of this group, Yaping Tu, PhD, in the Department of Pharmacology, studies prostate cancer and breast cancer. Tu recently received an award from the National Institutes of Health to study factors behind the resistance of breast cancer cells to promising treatments.

    Andrew E. Ekpenyong, PhD, and Michael Nichols, PhD, in the Department of Physics are examining how cancer drugs work at the cellular level and how such drugs could better combat metastasis, the spread of cancer from one part of the body to the other.

    Lynch Cancer Research Center

    Established in 1984, the Lynch Cancer Research Center at Creighton University is dedicated to comprehensive research regarding hereditary cancer syndromes. Cancer studies include breast and ovarian cancer, colon cancer, hematological cancer, pancreatic cancer and prostate cancer.

    Together, Creighton’s faculty and student researchers are expanding the horizons of discovery and removing barriers to conquering cancer.

    Image
    Exterior of the Hixson Lied Science Building

    Cancer Faculty Researchers

    Biomedical Sciences

    Chemistry

    Diagnostic Sciences (Dentistry)

    Medical Microbiology and Immunology

    Medicine

    Nursing

    Obstetrics and Gynecology

    Pathology

    Pharmacology

    Pharmacy Sciences

    Physical Therapy

    • Shana Harrington, PT, PhD, SCS

    Physics